CHICAGO (CN) – **Pfizer asked the Federal Court to order nonparties **The American Medical Association and the Journal of The American Medical Association to turn over “peer review comments, draft manuscripts, and correspondence with the authors” of articles about Celebrex and Bextra. The JAMA is willing to turn over only the published articles. See filing in Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

